Health ❯Medicine ❯Pharmacology ❯Weight Loss

Obesity Treatment

Oral GLP-1 Pill Orforglipron Delivers Phase III Weight Loss as Obesity Care Broadens Beyond Injections

Evidence this week underscores a shift to personalized obesity care built on behavior profiling alongside novel metabolic targets.

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3